We confirmed the modulation of H3S10ph using a different HMGA1–targeting siRNA, different triple-negative breast cancer (TNBC) cellular models (MDA-MB-157 and MDA-MB-468 cells), and a different α–H3S10ph antibody (Figure S1). Here, HMGA1 is linked to triple-negative breast carcinoma.